Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?
02:50pm, Monday, 11'th Nov 2024
BMY has been having a good run for the past three months. The stock recently touched a 52-week high.
Bristol Myers Squibb's stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
11:00am, Monday, 11'th Nov 2024
Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.
AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges
10:27am, Monday, 11'th Nov 2024
On Monday, AbbVie Inc ABBV stock is trading lower after it released data from its two Phase 2 EMPOWER trials of emraclidine for schizophrenia.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #AHA--Bristol Myers Squibb Showcases the Continued Strength of its Cardiovascular Portfolio with New Clinical and Real-World Evidence Data at AHA 2024.
The biopharmaceutical sector showed signs of recovery in the third quarter of 2024, fueled by increased investor optimism following the U.S. Federal Reserve's interest rate cuts in September.
What's Next For BMY Stock After An Upbeat Q3?
01:54am, Thursday, 07'th Nov 2024
Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates. It reported revenue of $11.9 billion and adjusted earnings of $1.80 per sh
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:01am, Wednesday, 06'th Nov 2024
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
05:00pm, Tuesday, 05'th Nov 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Participate in Upcoming Investor Conferences.
Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings
07:01am, Tuesday, 05'th Nov 2024
With many of the Magnificent 7 stocks reporting earnings the week of October 28, investors' attention was on technology stocks. But that means you may have overlooked two biopharmaceutical companies t
5 Must Own High-Yield Dividend Stocks If Kamala Harris Wins
04:55pm, Monday, 04'th Nov 2024
24/7 Wall St. Insights The seemingly endless political season is almost over.
Stock Market Rally Is 2 Years Old: 3 Passive Income Favorites Are November Bargains
07:47am, Saturday, 02'nd Nov 2024
24/7 Wall St. Insights The long AI-driven rally has many tech stocks overvalued.
Bristol-Myers Tops Q3 Earnings and Sales Estimates, Ups 2024 EPS View
12:10pm, Thursday, 31'st Oct 2024
BMY posts impressive third-quarter results, with both earnings and sales beating the respective estimates. The company also raises its annual earnings guidance.
Bristol-Myers Squibb Company (BMY) Q3 2024 Earnings Call Transcript
12:05pm, Thursday, 31'st Oct 2024
Bristol-Myers Squibb Company (NYSE:BMY ) Q3 2024 Results Conference Call October 31, 2024 8:00 AM ET Company Participants Chuck Triano - Senior Vice President, Investor Relations Chris Boerner - Board
Initial Claims Lower-Than-Expected
11:56am, Thursday, 31'st Oct 2024
Jobs Week trudges along this morning, with Friday morning's big Employment Situation report now on the horizon. Behind this stands the 2024 General Election — which could obviously sway the balance
Compared to Estimates, Bristol Myers (BMY) Q3 Earnings: A Look at Key Metrics
10:36am, Thursday, 31'st Oct 2024
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics
